Robert D. Tollefsen
FDA investigator
Appears on 1 document from 2015, mostly at sites in California. Most often cites stability testing (21 CFR 211.166(a)(2)).
- 1
- Documents on file
- 5.0
- Observations per 483
- 2015
- First seen
- 2015
- Most recent
What they cite most
From 5 observations- 21 CFR 211.166(a)(2)Stability testing2
- 21 CFR 211.160(b)(4)General requirements1
- 21 CFR 211.170(b)Reserve samples1
- 21 CFR 211.188(b)(8)Batch production and control records1
Activity by year
2015: 1
Where
California 1
Often inspects with
Is Robert D. Tollefsen coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2015-07-17 | 483 Novartis Pharmaceuticals CorporationJul 17, 2015 · San Carlos, California | San Carlos, California | 5 |
About this profile
What does Robert D. Tollefsen inspect?
Robert D. Tollefsen appears on 1 document on file covering 1 site, mostly in California.
What do they cite most often?
21 CFR 211.166(a)(2) (stability testing), followed by 21 CFR 211.160(b)(4) and 21 CFR 211.170(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Robert D. Tollefsen is dated Jul 17, 2015.